Boothbay Fund Management, LLC Eli Lilly & CO Call Options Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $4.64 Million - $5.82 Million	6,400 New	6,400 $5.79 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $2.24 Million - $2.63 Million	7,200 Added 50.7%	21,400 $7.35 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $18.5 Million - $21.6 Million	-57,600 Reduced 80.22%	14,200 $5.19 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $21 Million - $23.9 Million	70,700 Added 6427.27%	71,800 $23.2 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $473,841 - $556,359	-1,700 Reduced 60.71%	1,100 $357,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $657,132 - $816,648	2,800 New	2,800 $802,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $2.23 Million - $2.76 Million	-9,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.19 Million - $2.7 Million	9,900 New	9,900 $2.29 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.